cobas® EGFR Mutation Test v2

Device typeEpidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to predict or monitor the response to treatment with epidermal growth factor receptor (EGFR) inhibitors by determining the EGFR mutation status or mRNA expression of the EGFR gene, using a nucleic acid technique (NAT).

FDA categorySomatic gene mutation detection system

Device ID00875197005448

Catalog number07248563190

MRI safetyLabeling does not contain MRI Safety Information